These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 4632003)
21. Patent medicine. Baker D J Public Health Policy; 2001; 22(3):275-9. PubMed ID: 11603309 [No Abstract] [Full Text] [Related]
22. Commercial opportunities in United States health care in the 1970s. Hughes RL Trans Stud Coll Physicians Phila; 1974 Apr; 41(4):262-77. PubMed ID: 4827786 [No Abstract] [Full Text] [Related]
23. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry. Dorfman HL; Reig LP Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876 [No Abstract] [Full Text] [Related]
24. Paying for the biomedical future. Weber DO Health Forum J; 1999; 42(4):35. PubMed ID: 10539020 [No Abstract] [Full Text] [Related]
25. Developing medical schools: an interim report. Smythe CM J Med Educ; 1967 Nov; 42(11):991-1004. PubMed ID: 6080843 [No Abstract] [Full Text] [Related]
26. One course Sue Barton never took: health care economics. Bluestone N J Nurs Adm; 1973; 3(6):25-8. PubMed ID: 4202903 [No Abstract] [Full Text] [Related]
28. Changing needs are dictating new capital approaches. Rorem CR Hospitals; 1968 Oct; 42(20):48-54. PubMed ID: 4971568 [No Abstract] [Full Text] [Related]
29. Roundtable discussion. Cost justification of innovative drugs through assessment of total health care costs. Rybak MJ; Allen R; Craven PC; Freeman R; Nightingale CH; Normand C; Rubinstein E; Schaison GS; Whitelaw G Hosp Formul; 1993 Jan; 28 Suppl 1():33-6. PubMed ID: 10123836 [No Abstract] [Full Text] [Related]
30. The public stake in medical research. Tishler M Proc R Soc Med; 1968 Jul; 61(7):691-6. PubMed ID: 5664297 [No Abstract] [Full Text] [Related]
31. [European drug market--dream or nightmare?]. Nord Med; 1974 Jan; 89(1):6-8. PubMed ID: 4819431 [No Abstract] [Full Text] [Related]
32. Research in hospital services and delivery of care: new frontiers for study. McCarthy T Univ Mich Med Cent J; 1969; 35(2):104-6. PubMed ID: 4978911 [No Abstract] [Full Text] [Related]
33. Pharmaceutical expenditure compared across countries. van Mosseveld C Can J Clin Pharmacol; 2005; 12(3):e269-75. PubMed ID: 16373959 [TBL] [Abstract][Full Text] [Related]
34. How things work in the real world of hospital finance. Kirchner M Med Econ; 1978 Feb; 55(3):218-24, 229-30, 232 passim. PubMed ID: 10305586 [No Abstract] [Full Text] [Related]
35. Research, regulation and development of new pharmaceuticals: past, present and future. II. Lasagna L Am J Med Sci; 1972 Feb; 263(2):66-78. PubMed ID: 5017858 [No Abstract] [Full Text] [Related]
36. The role of public and private institutions in medical research. Bloch H Proc R Soc Med; 1968 Jul; 61(7):696-9. PubMed ID: 5664298 [No Abstract] [Full Text] [Related]
37. The great cost dilemma. Rummer P Hosp Financ Manage; 1976 Oct; 30(10):12, 14, 16 passim. PubMed ID: 10305216 [No Abstract] [Full Text] [Related]
38. Healthcare in the United States. Lesson five: The financing of healthcare. Riley WJ; Wagenfeld MO Radiol Manage; 1987; 9(2):19-23, 26-7. PubMed ID: 10312669 [No Abstract] [Full Text] [Related]
39. Seeing the duties to all. Zoloth L Hastings Cent Rep; 2001; 31(2):15-9. PubMed ID: 11478102 [No Abstract] [Full Text] [Related]
40. Health care reform and the pharmaceutical industry. Mossinghoff GJ Health Care Manag; 1994 Aug; 1(1):187-96. PubMed ID: 10152353 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]